Takeda

Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Endpoints
Takeda
Shire
Christophe Weber
M&A
Flag link:
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
M&A
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Biogen
Takeda
Regeneron
Alexion
Flag link:
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Fierce Pharma
Takeda
Shire
shareholders
M&A
Flag link:
Takeda makes $280M divestiture amid Shire buy
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Takeda
Shire
M&A
Guangdong Techpool Bio-Pharma
Flag link:
Takeda CEO Sees Path to Survival in Shire Megadeal
Takeda CEO Sees Path to Survival in Shire Megadeal
Bloomberg
Takeda
Shire
M&A
Pharma CEOs
Chris Weber
Flag link:
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Shire
Takeda
M&A
R&D
Flag link:
Takeda and Shire: A Pricey Marriage
Takeda and Shire: A Pricey Marriage
Motley Fool
Takeda
Shire
M&A
Flag link:
Janssen obtains FDA approval for Darzalex (multiple myeloma)
Janssen obtains FDA approval for Darzalex (multiple myeloma)
GoinPharma
Janssen
JNJ
Darzalex
Takeda
Velcade
Multiple Myeloma
FDA
Flag link:
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Endpoints
Takeda
Shire
M&A
Flag link:
Takeda to cut IT, marketing and sales jobs after Shire merger
Takeda to cut IT, marketing and sales jobs after Shire merger
Pharmaforum
Takeda
Shire
M&A
layoffs
Flag link:
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Fortune
Takeda
Shire
M&A
Flag link:
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Takeda Nears Deal to Buy Shire in Its Biggest Purchase
Bloomberg
Takeda
Shire
M&A
Flag link:
4 Huge Pharma Deals in 4 Months Is Just the Beginning
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
M&A
Takeda
Shire
Novartis
AveXis
Sanofi
Bioverativ
Celgene
Juno Therapeutics
Flag link:
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say
Fierce Pharma
Takeda
Shire
M&A
earnings
Flag link:
Takeda reaches preliminary deal to buy Shire for close to $65B
Takeda reaches preliminary deal to buy Shire for close to $65B
Endpoints
Takeda
Shire
M&A
Flag link:
Shire Shares Gain After Deal With Takeda Nears Completion
Shire Shares Gain After Deal With Takeda Nears Completion
Bloomberg
Shire
Takeda
M&A
Flag link:
After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer
After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer
Fierce Pharma
Shire
Takeda
M&A
Flag link:
Pressing for direct negotiations, Takeda adds cash to a meatier $63B bid to buy Shire
Pressing for direct negotiations, Takeda adds cash to a meatier $63B bid to buy Shire
Endpoints
Shire
Takeda
M&A
Flag link:
Allergan will not bid for Shire: Sources
Allergan will not bid for Shire: Sources
CNBC
Allergan
Shire
M&A
Takeda
Flag link:
A bidding war is brewing over $50 billion drugmaker Shire
A bidding war is brewing over $50 billion drugmaker Shire
Business Insider
Shire
Takeda
Allergan
M&A
Flag link:

Pages